Nitric oxide synthase inhibitors selectively reduce blood flow in tumour-associated neovasculature, suggesting NO maintains dilator tone in neoplastic tissue.
No takes yet. Share an insight, caveat, or question.
NOS inhibition may selectively target tumour perfusion in animals; leaves open translation to human oncology.
Andrade et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: